Avsar.
TH

Healthcare · Healthcare Service Provider

Thyrocare Technologies Ltd (THYROCARE)

₹564.25

Mkt cap
₹8,440 Cr
P/E ratio
52.50
P/B
15.33
Div yield
1.76%
ROE
28.40%
ROCE
35.40%
EPS (TTM)
₹10.75
Book value
₹37
52W range
350–565
Sector
Healthcare

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

NSE THYROCAREBSE 539871www.thyrocare.com
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthModerate
TechnicalsBullish
52-week range
−0.18% from high
₹564
₹350+61.42% from low₹565
Current
₹564.25
Prev close
₹565.25
Day
−0.18%
Price performance
1D
−0.18%
1W
+1.58%
1M
+9.10%
3M
+42.81%
6M
+19.01%
1Y
+45.78%
YTD
+22.88%

Financials

F
Revenue, profit & margin
P/E ratio
52.5×
THYROCARE is 24% above the sector median of 42.3×
THYROCARE52.5×
Sector median42.3×
 Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Trend
Sales136135148135154157177166187193217196224
Expenses111100110103121115129124130135145138149
Operating Profit25353832344248425758715875
OPM %18%26%25%23%22%27%27%25%30%30%33%30%34%
Other Income41333434553-15
Interest11111111111-02
Depreciation11101113131113171411122214
Profit before tax17252820233437284750633564
Tax %28%31%28%26%25%29%28%32%54%24%24%21%24%
Net Profit12172015172426192238482849
EPS in Rs0.791.091.280.971.121.521.681.201.362.453.021.822.96
Raw PDF

Earnings

EResults dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

CLast 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

Sas of Jun 2026
60.92%Promoter
Promoters60.92%
FIIs5.43%0.06
DIIs20.92%0.08
Public12.71%
Ownership trend

Peers

P7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Dr Lal Pathlabs₹1,723.3055.3628,8890.81%132−15.18%703+16.61%28.00%
Vijaya Diagnost.₹1,389.4082.6514,2960.14%48+34.56%219+26.63%21.29%
Metropolis Healt₹571.6560.3411,8520.35%51+74.43%425+22.99%17.77%
Thyrocare Tech.₹530.2552.498,4401.76%49+117.14%224+19.66%35.38%
Nephrocare Health Services₹636.4583.116,3860.00%30+22.11%266+21.18%15.48%
Krsnaa Diagnost.₹549.0517.351,7810.50%43+105.89%173−0.93%12.70%
Suraksha Diagno.₹261.4042.291,3610.00%6−15.02%81+25.07%16.97%
Median: 13 Co.₹549.0542.291,3610.00%18+23.59%173+21.18%23.27%

Filings

D
Annual reports11
Financial Year 2026bseFinancial Year 2025bseFinancial Year 2024bseFinancial Year 2023bseFinancial Year 2022bseFinancial Year 2021bseFinancial Year 2020bseFinancial Year 2019bseFinancial Year 2018bseFinancial Year 2017bseFinancial Year 2016bse
Concall transcripts64
TranscriptMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptOct 2025PPTOct 2025TranscriptJul 2025PPTJul 2025RECJul 2025TranscriptApr 2025PPTApr 2025RECApr 2025TranscriptJan 2025PPTJan 2025TranscriptOct 2024PPTOct 2024TranscriptJul 2024PPTJul 2024TranscriptMay 2024PPTMay 2024TranscriptFeb 2024PPTFeb 2024TranscriptNov 2023
Announcements5
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Jul - Filed Regulation 74(5) certificate for quarter ended June 30, 2026; no rematerialisation requests received.Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association 30 Jun - Members approved MOA amendment at 26th AGM on June 30, 2026, expanding business objects.Change In Statutory Auditors Of The Company 30 Jun - Shareholders approved Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from June 30, 2026.Shareholder Meeting / Postal Ballot-Outcome of AGM 30 JunClosure of Trading Window 24 Jun